Search research articles
Contact Us
Filters
Showing results (141-150 of 166) with videos related to
Page
of 17
Sort By:
Oncotarget
|
April 13, 2016
The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance
Kevin S Quackenbush, Stacey Bagby, Wai Meng Tai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial
Jessica S W Borgers, Cheng-Chang Wu, Theresa M Medina, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 29, 2026
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial
Jessica S W Borgers, Cheng-Chang Wu, Theresa M Medina, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 12, 2021
Results of a Multi-Institutional Phase 2 Clinical Trial for 4DCT-Ventilation Functional Avoidance Thoracic Radiation Therapy
Yevgeniy Vinogradskiy, Richard Castillo, Edward Castillo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 30, 2024
The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations
Tejas Patil, Dexiang Gao, Alexander Watson, et al.
Journal of the National Cancer Institute
|
June 30, 2023
The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma
Cera Nieto, Bettina Miller, Nathaniel Alzofon, et al.
Frontiers in Oncology
|
November 30, 2019
IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
Richard P Tobin, Kimberly R Jordan, Puja Kapoor, et al.
Angewandte Chemie (International Ed. in English)
|
September 13, 2025
Bandgap Engineering of Graphene Nanoribbon via High-Pressure Topochemical Synthesis
Peijie Zhang, Yunfan Fei, Qingchao Zeng, et al.
Journal of the American Chemical Society
|
September 9, 2020
Distance-Selected Topochemical Dehydro-Diels-Alder Reaction of 1,4-Diphenylbutadiyne toward Crystalline Graphitic Nanoribbons
Peijie Zhang, Xingyu Tang, Yida Wang, et al.
Breast Cancer Research : BCR
|
August 4, 2018
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer
Jennifer R Diamond, S G Eckhardt, Todd M Pitts, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 166) with videos related to
Sort By:
Page
of 17
Oncotarget
|
April 13, 2016
The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance
Kevin S Quackenbush, Stacey Bagby, Wai Meng Tai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial
Jessica S W Borgers, Cheng-Chang Wu, Theresa M Medina, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 29, 2026
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial
Jessica S W Borgers, Cheng-Chang Wu, Theresa M Medina, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 12, 2021
Results of a Multi-Institutional Phase 2 Clinical Trial for 4DCT-Ventilation Functional Avoidance Thoracic Radiation Therapy
Yevgeniy Vinogradskiy, Richard Castillo, Edward Castillo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 30, 2024
The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations
Tejas Patil, Dexiang Gao, Alexander Watson, et al.
Journal of the National Cancer Institute
|
June 30, 2023
The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma
Cera Nieto, Bettina Miller, Nathaniel Alzofon, et al.
Frontiers in Oncology
|
November 30, 2019
IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
Richard P Tobin, Kimberly R Jordan, Puja Kapoor, et al.
Angewandte Chemie (International Ed. in English)
|
September 13, 2025
Bandgap Engineering of Graphene Nanoribbon via High-Pressure Topochemical Synthesis
Peijie Zhang, Yunfan Fei, Qingchao Zeng, et al.
Journal of the American Chemical Society
|
September 9, 2020
Distance-Selected Topochemical Dehydro-Diels-Alder Reaction of 1,4-Diphenylbutadiyne toward Crystalline Graphitic Nanoribbons
Peijie Zhang, Xingyu Tang, Yida Wang, et al.
Breast Cancer Research : BCR
|
August 4, 2018
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer
Jennifer R Diamond, S G Eckhardt, Todd M Pitts, et al.
Page
of 17